Evogenix teams with UK firm Domantis
11 August, 2003 by Melissa TrudingerEvoGenix has signed an agreement with UK-based Domantis to apply its protein evolution and optimisation technology to one of Domantis's domain antibody therapeutic leads.
West Nile lookalike gives vaccine hope
08 August, 2003 by Jeremy TorrResearchers at the University of Queensland have developed a clone of the locally endemic Kunjin virus, and successfully trialled in mice it as a West Nile virus (WNV) vaccine.
Polartechnics ramps up for Italian job
08 August, 2003 by Jeremy TorrDevice maker Polartechnics is to focus on the Italian market for the introduction of its TruScreen cervical cancer diagnostic device, as a precursor to a major push into the European screening arena.
CSIRO licenses bio-bone
08 August, 2003 by Jeremy TorrCSIRO has formed a strategic alliance with UK-based medical device company AorTech producing spinal disc implants, using a unique polymer developed by Melbourne researchers.
Prima, Prana to team on Alzheimer's vaccine
08 August, 2003 by Melissa TrudingerMelbourne biotechs Prima BioMed and Prana Biotechnology will collaborate on a project to develop a vaccine for Alzheimer's disease, the companies announced today.
Ambri seals deal with Sydney biomed network
07 August, 2003 by Jeremy TorrBiosensor company Ambri is to set up a clinical trial and research link with Sydney's Royal North Shore Hospital as part of a wider deal with the BioMed North group of medical facilities.
Premier Bionics claims sleep trial success
07 August, 2003 by Melissa TrudingerPremier Bionics has announced a successful clinical trial for its AirwayClear device for non-invasive detection and diagnosis of obstructive sleep apnoea (OSA), providing support for commercial discussions and laying the groundwork for a larger trial.
Prima: we're OK until 2004
07 August, 2003 by Melissa TrudingerDespite dwindling cash reserves, Prima BioMed has reassured the Australian Stock Exchange that it has enough resources to support it at least through the first quarter of 2004.
Biostart invests in Qld start-up Farmacule
06 August, 2003 by Graeme O'NeillQueensland's government has bought a slice of farming's value-added future with a $125,000 investment in Farmacule Bioindustries..
Prana surges on new Alzheimer's lead
05 August, 2003 by Graeme O'NeillShares in Melbourne-based Prana Biotechnology Ltd (ASX:PBT, NASDAQ:PRAN) surged 18 per cent today on news that the company had selected a new, more potent lead compound as a potential preventative therapy and treatment for Alzheimer's disease and related neurodegenerative disorders.
Cochlear inventor: study confirmed my research
01 August, 2003 by Melissa TrudingerCochlear implant inventor Prof Graeme Clark said today that a US study released this week on the risk of meningitis in children receiving cochlear implants confirmed his findings from many years of research.
Clinical Cell Culture expands market
01 August, 2003 by Jeremy TorrWA based Clinical Cell Culture (C3) has signed a deal with US company Ventrex to manufacture the company’s ReCell autologous skin harvesting device, primarily for the plastic and cosmetic surgery markets.
Starpharma to launch clinical trials for HIV gel
01 August, 2003 by Melissa TrudingerStarpharma has been given the all-clear from the US FDA to begin clinical trials on their dendrimer-based microcidal gel for prevention of HIV infection.
BresaGen Q4 results show dwindling cash reserves
31 July, 2003 by Melissa TrudingerAdelaide-based company BresaGen only has enough cash to last until December, according to figures released by the company today.
Axon workstation wins R&D award
31 July, 2003 by Iain ScottASX-listed Axon Instruments has picked up an R&D 100 award for its OpusExpress 6000A electrophysiology workstation.
